AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF EPSTEIN-BARR VIRUS-POSITIVE AND -NEGATIVE LYMPHOPROLIFERATIVE DISORDERS ARISING IN ORGAN TRANSPLANT RECIPIENTS1-Reference-Cited by-同舟云学术

AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF EPSTEIN-BARR VIRUS-POSITIVE AND -NEGATIVE LYMPHOPROLIFERATIVE DISORDERS ARISING IN ORGAN TRANSPLANT RECIPIENTS1

Published:1997-05 Issue:9 Volume:63 Page:1200-1205
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Nalesnik Michael A.,Rao Abdul S.,Furukawa Hiro,Pham Si,Zeevi Adriana,Fung John J.,Klein George,Gritsch H. Albin,Elder Elaine,Whiteside Theresa L.,Starzl Thomas E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference40 articles.

1. Posttransplantation Lymphoproliferative Disorders in Solid Organ Recipients Are Predominantly Aggressive Tumors of Host Origin

2. Multivisceral Intestinal Transplantation: Surgical Pathology

3. B-cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on epstein–barr virus detection by in situ hybridization

4. Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review;Transplant International;2021-10-28

2. A treatise on endothelial biology and exosomes: homage to Theresa Maria Listowska Whiteside;HNO;2020-01-21

3. Promising immunotherapy: Highlighting cytokine‐induced killer cells;Journal of Cellular Biochemistry;2018-12-16

4. Duncan Syndrome;Atlas of Genetic Diagnosis and Counseling;2017

5. Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation;Transplantation Research;2016-08-02